Literature DB >> 2434176

Antagonism between (-)-N6-phenylisopropyladenosine and the calcium channel facilitator Bay K 8644, on guinea-pig isolated atria.

L Caparrotta, G Fassina, G Froldi, R Poja.   

Abstract

Antagonism between (-)-N6-phenylisopropyladenosine (PIA) and the dihydropyridine calcium channel facilitator Bay K 8644 was investigated in guinea-pig spontaneously beating or electrically driven isolated atria, taken from normal and from reserpine-treated animals. PIA (3-100 nM) produced a dose-dependent decrease in contractile tension and frequency in spontaneously beating atria being more effective in reserpinized preparations. Bay K 8644 (5-200 nM) produced an increase in contractile tension in both normal and reserpinized atria. In electrically driven left atria the positive inotropic effect of Bay K 8644 was similar to that in spontaneously beating preparations. The positive chronotropic effect of Bay K 8644 was slight and variable. PIA produced a rightward parallel shift of the concentration-response curves for the positive inotropic effects of Bay K 8644 in all experimental conditions. In spontaneously beating atria from normal guinea-pigs, the Schild regression plot was linear and its slope near to unity; pA2 of PIA 8.63 +/- 0.05 (IC50 2.35 +/- 0.25 nM). In electrically driven atria the antagonism by PIA of the effects of Bay K 8644 was apparently competitive, and the IC50 of PIA was 18.6 +/- 0.4 nM. PIA antagonized the positive chronotropic effect of Bay K 8644 in spontaneously beating preparations, both from normal and from reserpine-treated animals. Carbachol did not modify the positive inotropic effects of Bay K 8644. These data indicate that PIA may interact with Bay K 8644 at the level of the slow calcium channels, and may decrease the transmembrane calcium flux into the cell.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434176      PMCID: PMC1917292          DOI: 10.1111/j.1476-5381.1987.tb16821.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Electrophysiological and pharmacological evidence that peripheral type benzodiazepine receptors are coupled to calcium channels in the heart.

Authors:  M Mestre; T Carriot; C Belin; A Uzan; C Renault; M C Dubroeucq; C Guérémy; A Doble; G Le Fur
Journal:  Life Sci       Date:  1985-01-28       Impact factor: 5.037

2.  Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.

Authors:  K Ishii; N Taira; T Yanagisawa
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

3.  Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.

Authors:  G Thomas; R Gross; M Schramm
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

4.  Role of extracellular and intracellular adenosine in the attenuation of catecholamine evoked responses in guinea pig heart.

Authors:  J G Dobson; J Schrader
Journal:  J Mol Cell Cardiol       Date:  1984-09       Impact factor: 5.000

5.  Evidence for adenosine receptor-mediated isoprenaline-antagonistic effects of the adenosine analogs PIA and NECA on force of contraction in guinea-pig atrial and ventricular cardiac preparations.

Authors:  M Böhm; R Brückner; W Meyer; M Nose; W Schmitz; H Scholz; J Starbatty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

6.  Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog.

Authors:  Y Wada; K Satoh; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

7.  Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.

Authors:  H Glossmann; D R Ferry; A Goll; M Rombusch
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

8.  Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants.

Authors:  M Schramm; G Thomas; R Towart; G Franckowiak
Journal:  Arzneimittelforschung       Date:  1983

9.  Correlation of sinus slowing and hyperpolarization caused by adenosine in sinus node.

Authors:  G A West; L Belardinelli
Journal:  Pflugers Arch       Date:  1985-01       Impact factor: 3.657

10.  Inhibition by purines of the inotropic action of isoprenaline in rat atria.

Authors:  P R Hughes; T W Stone
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

View more
  6 in total

1.  Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs.

Authors:  R Z Gerencer; B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

2.  Involvement of purine compounds in the inotropic action of milrinone.

Authors:  P Dorigo; R M Gaion; I Maragno
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

3.  Effect of selective agonists and antagonists on atrial adenosine receptors and their interaction with Bay K 8644 and [3H]-nitrendipine.

Authors:  P A Borea; L Caparrotta; M De Biasi; G Fassina; G Froldi; L Pandolfo; E Ragazzi
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

4.  Regulation of oxygen radical production of human polymorphonuclear leukocytes by adenosine: the role of calcium.

Authors:  M Thiel; H Bardenheuer
Journal:  Pflugers Arch       Date:  1992-04       Impact factor: 3.657

5.  Comparison between the cardiac effects induced by muzolimine and furosemide in guinea-pig atria.

Authors:  P Dorigo; R M Gaion; M Bergamin; A Giacometti; E Valentini; I Maragno
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

6.  Potassium channel blockers differentially affect carbachol and (-)-N6-phenylisopropyladenosine on guinea-pig atria.

Authors:  M De Biasi; G Froldi; E Ragazzi; L Pandolfo; L Caparrotta; G Fassina
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.